Accuri Cytometers (Ann Arbor, MI) a commercial-stage device company focused on cell analysis flow cytometry, closed a $4M Series D financing. Participants include InvestMichigan-Credit Suisse, Fidelity Biosciences, Flagship Ventures, Baird Venture Partners and Arboretum Ventures.